These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1611854)

  • 1. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
    Segreti J; Kapell KS; Trenholme GM
    Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparison of cefoperazone/sulbactam with selected antimicrobials against 300 bacteroides isolates. Inhibitory activity and time-kill kinetic studies.
    Gelfand MS; Grogan JT; Haas MJ
    Diagn Microbiol Infect Dis; 1989; 12(5):421-8. PubMed ID: 2612130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
    Barry AL; Jones RN
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1830-2. PubMed ID: 2285302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative in vitro activity of ampicillin, cefoperazone, their combinations with sulbactam and other antibiotics with respect to staphylococci and pneumococci].
    Sidorenko SV; Rezvan SP; Speranskaia ON; Tikhonova As; Navashin SM; Ansolis LE; Tsvigun EA; Kuleshov SE; Budanov SV
    Antibiot Khimioter; 1995 Mar; 40(3):22-7. PubMed ID: 7575010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB; Bartelt MA; Chan EL; Dalton HP
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
    Fuchs PC; Stickel S; Anderson PH; Barry AL; Shilling S
    Antimicrob Agents Chemother; 1991 Jan; 35(1):182-4. PubMed ID: 2014975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species.
    Goldstein EJ; Citron DM
    J Antimicrob Chemother; 1996 Oct; 38(4):733-7. PubMed ID: 8937969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
    Rezvan SP; Sidorenko SV; Budanov SV
    Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of cefoperazone-sulbactam: Singapore experience.
    Kumarasinghe G; Chow C; Chiu C; Cheong YM
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):734-7. PubMed ID: 9253876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.
    Greenberg RN; Baker M; Meade DW; Chang Y; Danko LS
    J Antimicrob Chemother; 1993 Dec; 32(6):912-3. PubMed ID: 8144438
    [No Abstract]   [Full Text] [Related]  

  • 14. beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.
    Williams JD
    Clin Infect Dis; 1997 Mar; 24(3):494-7. PubMed ID: 9114205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates.
    Eliopoulos GM; Klimm K; Ferraro MJ; Moellering RC
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):624-6. PubMed ID: 2506024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.
    Rice LB; Carias LL; Etter L; Shlaes DM
    Antimicrob Agents Chemother; 1993 May; 37(5):1061-4. PubMed ID: 8390809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.
    Poudyal N; Gyawali N; Gurung R; Bhattarai NR; Baral R; Khanal B; Shrestha S; Amatya R; Bhattacharya SK
    Nepal Med Coll J; 2012 Mar; 14(1):5-8. PubMed ID: 23441486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.
    Chandrasekar PH; Sluchak JA
    Infection; 1991; 19(1):49-53. PubMed ID: 2013510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of gatifloxacin with cefoperazone and cefoperazone-sulbactam against resistant strains of Pseudomonas aeruginosa.
    Sivagurunathan N; Krishnan S; Rao JV; Nagappa AN; Subrahmanyam VM; Vanathi BM
    J Med Microbiol; 2008 Dec; 57(Pt 12):1514-1517. PubMed ID: 19018022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.